Amarin Corp. plc's purified EPA omega-3 fatty acid compound AMR101 bested investor expectations in a second Phase III study, sending the Dublin, Ireland-based firm's shares soaring 95 percent Monday and potentially catapulted the drug into a multi-billion-market opportunity. Read More
Active Biotech AB is banking an up-front payment of $35.6 million and could get $249.4 million more on the back of a partnering deal with Ipsen SA on its Phase III cancer drug tasquinimod (TASQ). Read More
San Diego-based CoDa Therapeutics Inc. raised $19.2 million in a Series B financing, allowing the biotech to a push forward with a large Phase II multicenter venous leg ulcer trial with Nexagon, its lead product for chronic wound patients. Read More
While they could have the answers in hand to the serious health issues facing workers at Japan's crippled Fukushima reactors, several biotechs may have to be content with learning the lessons of the ongoing disaster – and being ready for similar emergencies. Read More
Amylin Pharmaceuticals Inc., of San Diego, reported first quarter total revenue of $152.7 million on net product sales of $150.8 million, including $128 million for Byetta and $22.8 million for Symlin (pramlintide acetate), both for diabetes. Read More
Cytokinetics Inc., of South San Francisco, said additional Phase IIa data of CK-2017357 in patients with amyotrophic lateral sclerosis showed that, at 24 hours after each of the 250-mg and 500-mg doses, dose-related increases in the change from the day one baseline in percent predicted muscle strength achieved nominal statistical significance for elbow flexion (p = 0.005 and 0.0004, respectively). Read More
Regeneron Pharmaceuticals Inc., of Tarrytown, N.Y., said the FDA has accepted for review the company's biologics license application for VEGF Trap-Eye for the treatment of the neovascular form of age-related macular degeneration (wet AMD) and granted the company's request for priority review. The target date for an FDA decision on the VEGF Trap-Eye BLA is Aug. 20. Read More
